Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. Saigon Eye Hospital Chain (SGEH) receives accolades at Healthcare Asia Awards 2026 2. Hospital Authority confirms data leak affecting 56,000 patients 3. How can hospitals turn medical advances into system value? 4. Pun Hlaing Hospitals, Capital Retail to boost heathcare accessibility in Myanmar 5. Pharma and biotech wearables market to reach $9.97b by 2031Resource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
The centre was recognised for advancing endoscopic innovation and multidisciplinary integration.
Commentary
Public health at scale: Lessons from implementing AI across government health programmes
Clearing the air: Why Singapore's haze problem is an eldercare crisis in plain sight
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings